These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23511495)

  • 1. MPL Baltimore mutation and thrombocytosis: case report and literature review.
    Shkalim-Zemer V; Dgany O; Krasnov T; Yacobovich J; Tamary H
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e112-4. PubMed ID: 23511495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene.
    El-Harith el-HA; Roesl C; Ballmaier M; Germeshausen M; Frye-Boukhriss H; von Neuhoff N; Becker C; Nürnberg G; Nürnberg P; Ahmed MA; Hübener J; Schmidtke J; Welte K; Stuhrmann M
    Br J Haematol; 2009 Jan; 144(2):185-94. PubMed ID: 19036112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.
    Moliterno AR; Williams DM; Gutierrez-Alamillo LI; Salvatori R; Ingersoll RG; Spivak JL
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11444-7. PubMed ID: 15269348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation.
    Verger E; Teillet F; Conejero C; Letort G; Chomienne C; Giraudier S; Cassinat B
    Br J Haematol; 2016 Oct; 175(1):167-9. PubMed ID: 26568271
    [No Abstract]   [Full Text] [Related]  

  • 5. An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.
    Favale F; Messaoudi K; Varghese LN; Boukour S; Pecquet C; Gryshkova V; Defour JP; Albu RI; Bluteau O; Ballerini P; Leverger G; Plo I; Debili N; Raslova H; Favier R; Constantinescu SN; Vainchenker W
    Blood; 2016 Dec; 128(26):3146-3158. PubMed ID: 28034873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of MPL Baltimore using LightCycler technology and melting curve analysis.
    Standen G; Clench T
    Br J Haematol; 2008 Mar; 140(6):714-6. PubMed ID: 18302717
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.
    Teofili L; Giona F; Torti L; Cenci T; Ricerca BM; Rumi C; Nunes V; Foà R; Leone G; Martini M; Larocca LM
    Haematologica; 2010 Jan; 95(1):65-70. PubMed ID: 19713221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients.
    Al-Harbi T; Al-Zahrani M; Al-Balwi M; Al-Hazmi A; Alsuhaibani A; Aljafn N; Alsumari F; Aleshaiwi L; Alsuhibani A; Alqasim O; Ahmad N
    Br J Haematol; 2021 Sep; 194(5):893-898. PubMed ID: 34131895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.
    McMullin MF
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):391-396. PubMed ID: 31808840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family with hereditary thrombocythaemia and normal genes for thrombopoietin and c-Mpl.
    Tecuceanu N; Dardik R; Rabizadeh E; Raanani P; Inbal A
    Br J Haematol; 2006 Nov; 135(3):348-51. PubMed ID: 16995886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis.
    Alzahrani M; Al Turki S; Al Rajban W; Alshalati F; Almodaihsh F; Abuelgasim KA; Alahmari B; Al Bogami T; Ali O; Al Harbi T; AlBalwi MA; Alotaibi M; Aleem A; Al Asker A; Al Mugairi A
    Platelets; 2022 Nov; 33(8):1220-1227. PubMed ID: 35791502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.
    Liu K; Martini M; Rocca B; Amos CI; Teofili L; Giona F; Ding J; Komatsu H; Larocca LM; Skoda RC
    Haematologica; 2009 Oct; 94(10):1368-74. PubMed ID: 19608689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
    Vasseur L; Favier R; Kim R; Rabian F; Cabannes-Hamy A; Cassinat B; Maslah N; Vasquez N; Clappier E; Kiladjian JJ; Boissel N
    Pediatr Blood Cancer; 2023 Feb; 70(2):e29905. PubMed ID: 35924408
    [No Abstract]   [Full Text] [Related]  

  • 14. The S505A thrombopoietin receptor mutation in childhood hereditary thrombocytosis and essential thrombocythemia is S505N: single letter amino acid code matters.
    Defour JP; Levy G; Leroy E; Smith SO; Constantinescu SN
    Leukemia; 2019 Feb; 33(2):563-564. PubMed ID: 30635630
    [No Abstract]   [Full Text] [Related]  

  • 15. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
    Szpurka H; Gondek LP; Mohan SR; Hsi ED; Theil KS; Maciejewski JP
    Leukemia; 2009 Mar; 23(3):610-4. PubMed ID: 18818701
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm.
    Bernal M; Jiménez P; Puerta J; Ruíz-Cabello F; Jurado M
    Ann Hematol; 2017 Aug; 96(8):1399-1401. PubMed ID: 28516193
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in understanding the pathogenesis of familial thrombocythaemia.
    Teofili L; Larocca LM
    Br J Haematol; 2011 Mar; 152(6):701-12. PubMed ID: 21303356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis.
    Voirin E; Bouvier A; Plo I; Durix L; Beucher A; Giraudier S; Ugo V; Brasme JF; Luque Paz D
    Am J Hematol; 2024 Aug; 99(8):1644-1646. PubMed ID: 38752375
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of familial thrombocytosis: possible role of altered thrombopoietin production.
    Fujiwara T; Harigae H; Kameoka J; Yokoyama H; Takahashi S; Tomiya Y; Yamada M; Ishizawa K; Imaizumi M; Sasaki T
    Am J Hematol; 2004 Aug; 76(4):395-7. PubMed ID: 15282677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the Ashkenazi Jewish population.
    Jalas C; Anderson SL; Laufer T; Martimucci K; Bulanov A; Xie X; Ekstein J; Rubin BY
    Blood Cells Mol Dis; 2011 Jun; 47(1):79-83. PubMed ID: 21489838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.